Results 71 to 80 of about 40,192 (253)

Durable remission of leptomeningeal metastases from hormone-responsive prostate cancer

open access: yes, 2011
Prostate cancer is rarely associated with leptomeningeal metastasis. An 87-year-old man with a history of prostate cancer presented with leptomeningeal metastasis. He received hormonal therapy with leuprolide.
Santosh Kesari   +9 more
core   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay   +5 more
wiley   +1 more source

Olaparib treatment for BRCA-mutant ovarian cancer with leptomeningeal disease [PDF]

open access: yes, 2016
HIGHLIGHTS: Leptomeningeal disease occurs more commonly in BRCA-mutated ovarian cancer; A clinically significant dose of olaprib is able to penetrate the leptomeninges; Leptomeningeal metastases in a BRCA-mutated ovarian cancer responded to ...
Goldstein, R   +3 more
core  

Leptomeningeal carcinomatosis of gastric adenocarcinoma

open access: yes, 2011
Gastric cancer is the third most common malignancy among gastrointestinal malignancies. With the advance of new treatments, overall survival in gastric cancer is extending, and metastasis to atypical sites is seen more commonly. Leptomeningeal metastasis
Bulut, Gulcan   +7 more
core   +1 more source

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆

open access: yes, 2023
This Clinical Practice Guideline provides recommendations for managing leptomeningeal metastases from solid ...
Schadendorf D.   +14 more
core   +1 more source

Vocational and Educational Outcomes in Adults With Sturge–Weber Syndrome: Preliminary Results From a Clinical Needs Assessment

open access: yesAnnals of the Child Neurology Society, EarlyView.
ABSTRACT Objective The clinical presentation of Sturge–Weber syndrome (SWS) is highly variable, with seizures during infancy and co‑occurring neurodevelopmental conditions commonly reported. Although these features are known to affect childhood functioning, their relationship to adult vocational and educational outcomes remains poorly understood.
Katharine E. Joslyn   +3 more
wiley   +1 more source

Leptomeningeal metastasis mimicking Chronic Subdural Hematoma [PDF]

open access: yes, 2017
The presentation of Leptomeningeal Metastasis varies widely. It can also present a condition very similar to Chronic Subdural Hematoma. One should have a low threshold for suspicion while diagnosing such conditions to avoid catastrophic events.
Jain, Saurabh, Saurabh Jain
core   +2 more sources

Management of leptomeningeal malignancy

open access: yesExpert Opinion on Pharmacotherapy, 2005
Leptomeningeal carcinomatosis is defined as malignant infiltration of the pia matter and arachnoid membrane. Leukaemias and lymphomas, lung, breast cancer and melanoma are the primary tumours commonly associated with leptomeningeal carcinomatosis.
Pentheroudakis, George   +3 more
openaire   +4 more sources

Leptomeningeal melanoma in childhood [PDF]

open access: yesCancer, 1999
Malignant melanoma (MM) is one of the least common types of childhood cancer, accounting for less than 1% of all pediatric malignancies. Neurocutaneous melanosis (NCM) is a rare phakomatosis consisting of congenital abnormal pigmentation of the skin and meninges.
G W, Makin   +8 more
openaire   +2 more sources

Primary leptomeningeal lymphoma [PDF]

open access: yes, 2013
ObjectiveTo evaluate clinical presentation, optimal diagnostic evaluation and treatment, and outcome in primary leptomeningeal lymphoma, a rare form of primary CNS lymphoma without parenchymal or systemic involvement.MethodsThe International Primary CNS ...
Omuro, Antonio   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy